{
    "code": "01055934",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01055934",
    "time": "2021-01-08 03:53:02",
    "許可證字號": "衛署藥製字第055934號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/02\/14",
    "發證日期": "100\/02\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105593406",
    "中文品名": "“杏輝”杏瑞鉑靜脈注射液5毫克\/毫升",
    "英文品名": "ORECTALIP IV INJECTION 5MG\/ML“Sinphar”",
    "適應症": "和5-fluorouracil (5-FU)及folinic acid (FA)併用，作為第三期結腸癌(Duke’s C)原發腫瘤完全切除手術後的輔助療法。治療轉移性結腸直腸癌。Oxaliplatin和fluoropyrimidine類藥物併用可用於局部晚期及復發\/轉移性胃癌之治療。與5-fluorouracil、leucovorin及irinotecan合併治療(FOLFIRINOX)，作為轉移性胰臟癌之第一線治療藥物。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 10毫升、20毫升、40毫升透明玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OXALIPLATIN",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "0705330200  杏輝藥品工業股份有限公司",
    "申請商地址": "宜蘭縣冬山鄉中山村中山路84號、新寮路95號、103號(同一廠區)",
    "主製造廠": [
        {
            "製造廠名稱": "0705330300  杏輝藥品工業股份有限公司",
            "製造廠廠址": "宜蘭縣冬山鄉中山村中山路８４號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "澄清無色液體",
        "特殊劑型": "",
        "顏色": "無色",
        "特殊氣味": "無",
        "刻痕": "無",
        "形狀": "",
        "標記一": "無",
        "標記二": "無"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "杏瑞鉑靜脈注射液5毫克／毫升(20ml)-藥物外觀-104-10-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "570559340001-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=009&Type=9"
        },
        {
            "title": "“杏輝”杏瑞鉑靜脈注射液5毫克毫升_仿單-107-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=008&Type=9"
        },
        {
            "title": "570559340001-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=007&Type=9"
        },
        {
            "title": "010559340003-104-01-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=006&Type=9"
        },
        {
            "title": "570559340003-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=013&Type=8"
        },
        {
            "title": "570559340002-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=012&Type=8"
        },
        {
            "title": "570559340001-109-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=011&Type=8"
        },
        {
            "title": "“杏輝”杏瑞鉑靜脈注射液5毫克毫升_外盒-107-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=010&Type=8"
        },
        {
            "title": "“杏輝”杏瑞鉑靜脈注射液5毫克毫升_標籤-107-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=009&Type=8"
        },
        {
            "title": "570559340002-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=008&Type=8"
        },
        {
            "title": "570559340001-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=007&Type=8"
        },
        {
            "title": "570559340002-105-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055934&Seq=006&Type=8"
        }
    ]
}